Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / A New Clue in Developmental Disorders
Neurology Biochemistry and molecular biology Genetics and epigenetics Insights

A New Clue in Developmental Disorders

Bi-allelic mutations associated with intellectual disability and brain abnormalities

02/20/2026 News 2 min read

Share

Bi-allelic variants in the ASTN1 gene have been linked to a range of neurodevelopmental disorders, according to a study published in The American Journal of Human Genetics.

The ASTN1 gene encodes astrotactin 1, a protein involved in neuronal migration during brain development. This process allows neurons to move to their correct positions in the developing brain, which is essential for normal formation of structures such as the cerebral cortex and cerebellum. Disruption of this process can lead to structural brain abnormalities and developmental impairment.

In the study, researchers identified 18 individuals from 12 unrelated families who carried ultra-rare, likely damaging variants affecting both copies of ASTN1. Most affected individuals had developmental delay or intellectual disability, ranging from mild to severe. Additional clinical features included autism spectrum disorder, attention-deficit/hyperactivity disorder, epilepsy, low muscle tone, movement abnormalities, and dysmorphic facial features.

Brain imaging findings were variable. Some individuals had normal magnetic resonance imaging results, while others showed abnormalities such as a thin corpus callosum, cerebellar changes, polymicrogyria, or lissencephaly. This variability suggests that ASTN1-related disorders may present with a broad clinical spectrum.

The study also identified different genetic patterns within the cohort. Most individuals had recessive, bi-allelic variants in ASTN1. One individual carried heterozygous variants in both ASTN1 and ASTN2, a related gene involved in neuronal migration, suggesting a possible combined genetic effect. In some cases, multilocus pathogenic variation was observed, meaning that more than one gene contributed to the phenotype.

These findings highlight the importance of comprehensive genomic testing in patients with unexplained neurodevelopmental disorders. Exome or genome sequencing may identify rare bi-allelic variants that could be missed by more limited testing panels. The study also emphasizes the need to consider complex inheritance patterns, including potential contributions from more than one gene.

Recognition of ASTN1 as a gene associated with neurodevelopmental disorders may support more accurate diagnosis, improved genetic counseling, and better-informed family risk assessment as genomic testing becomes more widely used in pediatric and neurological practice.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.